This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
06/30/15 - 3:59:59 PM ET (BATS BZX Real-time Price)
Div Yield: --
ALNY Day's Range
ALNY 52 Week Range
ALNY Business Summary
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapeutics based on RNA interference.View ALNY key stats
Alnylam Pharmaceuticals Inc - ALNY - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Alnylam Pharmaceuticals Inc as a
Hold with a ratings score of C-.
Report Snippet: We rate ALNYLAM PHARMACEUTICALS INC (ALNY) a HOLD. The primary factors that have impacted our rating are mixed - some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we find that the company's return on equity has been disappointing.